A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Jillian Gunther, MD,PHD) · jgunther@mdanderson.org · 832-710-7864
Contact: Principal Investigator (Jillian Gunther, MD,PHD)

Study leads

Jillian Gunther, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Follicular Lymphoma · Lymphoma

Abroad (travel likely)RecruitingPHASE2

Washington D.C., United States · Basking Ridge, United States

Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL

Anaplastic Large Cell Lymphoma, ALK-Positive

Abroad (travel likely)RecruitingPHASE2

Valhalla, United States

Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Primary Central Nervous System Lymphoma (PCNSL) · Diffuse Large B Cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE2

Beijing, China

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Acute Leukemia · Lymphoblastic Leukemia · Lymphoblastic Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chicago, United States · Rochester, United States